Three Times Daily Dosing of UT-15C
Completed · Phase 1
Conditions studied: Healthy
In brief
To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers
Key facts
- Study ID
- NCT01746485
- Run by
- United Therapeutics
- People needed
- 19
- Starts
- 2012-07-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2012-12-12
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- PPD Development — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.